Wells Fargo
OMGA

Wells Fargo’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Wells Fargo’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,440
Closed -$13.7K – 7349
2024
Q4 		$13.7K Sell
18,440
-5,000
-21% -$4.98K ﹤0.01% 5860
2024
Q3 		$28.6K Hold
23,440
– – ﹤0.01% 5535
2024
Q2 		$48.5K Sell
23,440
-8,263
-26% -$19.5K ﹤0.01% 5303
2024
Q1 		$116K Buy
31,703
+11,976
+61% +$45.9K ﹤0.01% 4808
2023
Q4 		$59.4K Buy
19,727
+1,435
+8% +$2.91K ﹤0.01% 5203
2023
Q3 		$39.3K Buy
18,292
+8,150
+80% +$32.6K ﹤0.01% 5308
2023
Q2 		$56.8K Buy
10,142
+10,019
+8,146% +$78.4K ﹤0.01% 5371
2023
Q1 		$742 Buy
123
+2
+2% +$14 ﹤0.01% 6458
2022
Q4 		$691 Buy
121
+3
+3% +$17 ﹤0.01% 6293
2022
Q3 		$1K Buy
118
+67
+131% +$339 ﹤0.01% 6502
2022
Q2 		$0 Sell
51
-14,276
-100% -$53.2K ﹤0.01% 7675
2022
Q1 		$89K Buy
14,327
+1,111
+8% +$11.3K ﹤0.01% 5385
2021
Q4 		$150K Buy
13,216
+13,175
+32,134% +$251K ﹤0.01% 5430
2021
Q3 		$1K Buy
+41
New +$786 ﹤0.01% 6827

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wells Fargo's OMGA Position: Q1 2025 in Review

Wells Fargo sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 18,440 shares — an estimated $13.7K sold.

Wells Fargo first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $150K in Q4 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Wells Fargo reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 18,440 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $13.7K.
  • Wells Fargo first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Wells Fargo's Omega Therapeutics, Inc. Common Stock position peaked at $150K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.